Filing Details
- Accession Number:
- 0001225208-19-011835
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-08-22 20:51:47
- Reporting Period:
- 2019-08-22
- Accepted Time:
- 2019-08-22 20:51:47
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1099800 | Edwards Lifesciences Corp | EW | Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) | 364316614 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1204551 | A Michael Mussallem | One Edwards Way Irvine CA 92614 | Chairman & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-08-22 | 32,850 | $35.79 | 95,770 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-08-22 | 300 | $212.97 | 95,470 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-08-22 | 601 | $221.34 | 94,869 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-08-22 | 700 | $212.04 | 94,169 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-08-22 | 800 | $219.65 | 93,369 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-08-22 | 1,700 | $218.55 | 91,669 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-08-22 | 1,700 | $217.02 | 89,969 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-08-22 | 2,099 | $220.76 | 87,870 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-08-22 | 2,525 | $215.41 | 85,345 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-08-22 | 2,600 | $214.25 | 82,745 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-08-22 | 9,825 | $216.37 | 72,920 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-08-22 | 10,000 | $0.00 | 62,920 | No | 5 | G | Direct | |
| Common Stock | Acquisiton | 2019-08-22 | 10,000 | $0.00 | 775,400 | No | 5 | G | Indirect | By Living Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 5 | G | Direct | |
| No | 5 | G | Indirect | By Living Trust |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Acquire) | Acquisiton | 2019-08-22 | 32,850 | $0.00 | 32,850 | $35.79 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 361,350 | 2013-06-14 | 2020-05-13 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 123,925 | Indirect | 401(k) |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 26, 2019.
- This transaction was executed in multiple trades at prices ranging from $212.57 to $213.26. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $221.13 to $222.62. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $211.51 to $212.48. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $219.09 to $220.01. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $218.03 to $218.96. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $216.8450 to $217.55. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $220.12 to $221.08. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $214.84 to $215.83. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $213.62 to $214.57. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $215.84 to $216.8150. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
- Shares represented on the most recent statement of Issuer's 401(k) Plan Administrator.
Billionaire Hedge Funds
